Locations
San Francisco, CA, USA · Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
11-50 employees
founded in
2013
Helix Nano is focused on building next-generation mRNA technologies, vaccines, and therapies aimed at enhancing the immune system's ability to combat diseases. The company is leveraging synthetic biology and artificial intelligence to develop innovative solutions, including cancer vaccines and COVID-19 vaccine candidates. Their approach emphasizes precision and safety, positioning them as a forward-thinking player in the biotech space with a commitment to long-term impact. Helix Nano's unique differentiation lies in its advanced mRNA technology and rapid development capabilities, which are critical in addressing current and future health challenges.
Something looks off?